Financialsexperimental
MARIMED INC. (MRMD). Every figure is as filed in the company's 10-Q and 10-K reports. Quarters a filing does not report on their own are worked out from its year-to-date figures and marked *.
USD in thousands
| Balance Sheet | FY FY25 31 Dec 2025 | FY FY24 31 Dec 2024 | FY FY23 31 Dec 2023 | FY FY22 31 Dec 2022 | FY FY21 31 Dec 2021 |
|---|---|---|---|---|---|
| Cash and cash equivalents | 7,282 | 14,645 | 9,737 | 29,683 | |
| Cash, cash equivalents and restricted cash | 8,884 | ||||
| Accounts receivable, net of allowances of $819 and $287 at June 30, 2026 and December 31, 2025, respectively | 9,114 | 8,742 | 7,199 | 4,157 | 1,666.2 |
| Inventory | 36,601 | 33,488 | 25,306 | 19,477 | 9,767.9 |
| Deferred rents receivable | 0 | 556 | 630 | 704 | 1,677.7 |
| Notes receivable, current portion | 866 | 52 | 52 | 2,637 | 126.7 |
| Other current assets | 3,825 | 3,389 | 3,407 | 7,282 | 1,440.8 |
| Total current assets | 59,290 | 53,509 | 51,432 | 44,146 | 44,613 |
| Investments, current portion | 0 | 88 | 123 | 250.6 | |
| Property and equipment, net | 89,385 | 94,167 | 89,103 | 71,641 | 62,150.1 |
| Due from related parties | 29,000 | ||||
| Due from related parties | 105 | ||||
| Intangible assets, net | 17,210 | 18,639 | 17,012 | 14,201 | 2,230.3 |
| Goodwill | 24,002 | 15,812 | 11,993 | 8,079 | |
| Notes receivable, net of current portion | 0 | 840 | 814 | 7,467 | 8,986.6 |
| Operating lease right-of-use assets | 7,723 | 8,730 | 9,716 | 4,931 | 5,081.2 |
| Finance lease right-of-use assets | 4,024 | 4,073 | 3,295 | 713 | 45.7 |
| Investments, net of current portion | 0 | 221 | |||
| Other assets | 931 | 11,219 | 12,537 | 1,024 | 98 |
| Total assets | 202,565 | 206,989 | 196,123 | 152,202 | 123,204.9 |
| Mortgages and notes payable, current portion | 2,553 | 5,126 | 723 | 3,774 | 9.9 |
| Accounts payable | 14,586 | 13,189 | 9,001 | 6,626 | 5,098.5 |
| Mortgages and notes payable, current portion | 1,400.3 | ||||
| Accrued expenses and other | 9,509 | 4,435 | 3,549 | 3,091 | 1,348.7 |
| Deferred revenue | 1,394 | ||||
| Income taxes payable | 26,981 | 21,922 | 14,434 | 11,489 | 16,467.3 |
| Operating lease liabilities, current portion | 1,952 | 1,988 | 1,945 | 1,273 | 1,071.1 |
| Sales and excise taxes payable | 1,797.8 | ||||
| Finance lease liabilities, current portion | 2,092 | 2,018 | 1,210 | 237 | 27.1 |
| Total current liabilities | 59,067 | 48,678 | 30,862 | 26,490 | 27,222.6 |
| Mortgages and notes payable, net of current portion | 70,192 | 69,860 | 65,652 | ||
| Operating lease liabilities, net of current portion | 6,616 | 7,549 | 8,455 | 4,173 | 4,573.9 |
| Finance lease liabilities, net of current portion | 1,956 | 1,926 | 2,140 | 461 | 22.5 |
| Mortgages and notes payable, net of current | 25,943 | 448.3 | |||
| Total liabilities | 137,831 | 128,113 | 107,209 | 57,167 | 49,180.9 |
| Other current liabilities | 1,920 | ||||
| Other liabilities | 0 | 100 | 100 | 100 | 100.2 |
| Mortgages payable, less current portion | 16,813.5 | ||||
| Total mezzanine equity | 14,725 | 19,000 | 19,000 | 37,725 | 37,725 |
| Undesignated preferred stock, $0.001 par value; 32,659,235 shares authorized; zero shares issued and outstanding at June 30, 2026 and December 31, 2025 | 0 | 0 | 0 | 0 | |
| Common stock, $0.001 par value; 700,000,000 shares authorized; 401,167,467 and 396,911,368 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively | 397 | 381 | 375 | 341 | 334 |
| Additional paid-in capital | 179,405 | 173,366 | 171,144 | 142,365 | 134,920.4 |
| Accumulated deficit | -127,932 | -112,119 | -99,955 | -83,924 | -97,392 |
| Noncontrolling interests | -1,861 | -1,752 | -1,650 | -1,511 | -1,563.4 |
| Common stock subscribed but not issued; 70,000 and zero shares at December 31, 2022 and 2021, respectively | 39 | ||||
| Total stockholders’ equity | 50,009 | 59,876 | 69,914 | 57,310 | 36,299 |
| Total liabilities, mezzanine equity and stockholders’ equity | 202,565 | 206,989 | 196,123 | 152,202 | 123,204.9 |
| Common stock subscribed but not issued | 0 | ||||
| Total mezzanine equity — Series BConvertible Preferred Stock | 14,725 | 14,725 | 14,725 | 14,725 | |
| Total mezzanine equity — Series BConvertible Preferred Stock | 14,725 | ||||
| Total mezzanine equity — Series CConvertible Preferred Stock | 23,000 | ||||
| Total mezzanine equity — Series CConvertible Preferred Stock | 0 | 4,275 | 4,275 | 23,000 |